Publicaciones en colaboración con investigadores/as de Hospital Universitario Reina Sofia (11)

2023

  1. Neoadjuvant Chemotherapy plus Interval Cytoreductive Surgery with or without Hyperthermic Intraperitoneal Chemotherapy (NIHIPEC) in the Treatment of Advanced Ovarian Cancer: A Multicentric Propensity Score Study

    Cancers, Vol. 15, Núm. 17

  2. Recommendations for the optimal management of peritoneal metastases in patients with colorectal cancer: a TTD and GECOP-SEOQ expert consensus statement

    Clinical and Translational Oncology, Vol. 25, Núm. 12, pp. 3378-3394

2022

  1. GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases

    BMC Cancer, Vol. 22, Núm. 1

2020

  1. Intraperitoneal hyperthermic chemotherapy after cytoreduction in patients with peritoneal metastases from endometrial cancer. The next frontier?

    Surgical Oncology, Vol. 33, pp. 19-23

  2. Secondary surgical cytoreduction needs to be assessed taking into account surgical technique, completeness of cytoreduction, and extent of disease

    World Journal of Surgical Oncology, Vol. 18, Núm. 1

  3. Survival outcomes in patients aged 75 years and over with peritoneal colorectal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): multicenter study of the Spanish Group of Peritoneal Cancer Surgery (GECOP)

    Clinical and Translational Oncology, Vol. 22, Núm. 1, pp. 130-136

2019

  1. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP)

    Annals of Surgical Oncology, Vol. 26, Núm. 8, pp. 2615-2621

  2. RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis: A Modification Proposal of the Peritoneal Surface Disease Severity Score

    Annals of Surgical Oncology, Vol. 26, Núm. 8, pp. 2595-2604

2018

  1. Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey

    European Journal of Surgical Oncology, Vol. 44, Núm. 2, pp. 228-236

2016

  1. Morbidity and mortality outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients aged 75 years and over: Spanish group of peritoneal cancer surgery (GECOP) multicenter study

    Surgical Oncology, Vol. 25, Núm. 2, pp. 111-116

2009

  1. Ovarian peritoneal mucinous carcinomatosis and pseudomyxoma peritonei of ovarian origin. Are they the same?

    Cirugía española, Vol. 85, Núm. 1, pp. 55-57